International research for acute myocardial infarction lacks comparisons of whole health systems. We assessed time trends for care and outcomes in Sweden and the UK.
Ivabradine's safety profile in severe HF was indistinguishable from less severe. In conclusion, our analysis confirms that heart rate reduction with ivabradine can be safely used in severe HF and may improve clinical outcomes independently of disease severity.
February 14 is the deadline for abstract submission to European Society of Cardiology Congress 2014 to be held in Barcelona, Spain from August 30 to September 3, 2014.
Having an acute upper respiratory tract infection -- with or without treatment with an antibiotic -- may be associated with excessive anti-coagulation in patients taking warfarin, a retrospective study showed, but the absolute risk of harm was low.
To assess whether granulocyte colony-stimulating factor treatment induces a sustained benefit on adverse remodelling in patients with large anterior ST-elevation myocardial infarction and left ventricular dysfunction after successful reperfusion.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.